Literature DB >> 2257635

Absorption enhancers.

S Muranishi1.   

Abstract

Many current therapeutic drugs, e.g., antibiotics and peptide drugs, are impermeable to outer tissue barriers. Drug delivery of impermeable drugs through such barriers is currently one of the major interests in pharmaceutical research. New classes of absorption enhancers provide rapid absorption in the gastrointestinal tract or skin, with no side effects. This review covers the history of enhancer research, an overview of a variety of absorption enhancers, the nature of enhancing action, and site specificity. The final section focuses on the mechanisms of enhancer action which transiently abolishes or reverses barrier resistance, from the viewpoints of the lipid bilayer barrier containing SH proteins, as well as transcellular/paracellular pathways. Fully understanding these mechanisms is of importance for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257635

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  34 in total

1.  Metabolism of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, by intestinal microorganisms.

Authors:  I Sasaki; T Tamura; T Shibakawa; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 2.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

4.  Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2005-12       Impact factor: 5.121

5.  Combining Chemical Permeation Enhancers for Synergistic Effects.

Authors:  Trizel du Toit; Maides M Malan; Hendrik J R Lemmer; Chrisna Gouws; Marique E Aucamp; Wilma J Breytenbach; Josias H Hamman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

6.  Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.

Authors:  A Fasano; S Uzzau
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 7.  Non-invasive delivery strategies for biologics.

Authors:  Aaron C Anselmo; Yatin Gokarn; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2018-11-30       Impact factor: 84.694

8.  Regional rectal perfusion: a new in vivo approach to study rectal drug absorption in man.

Authors:  H Lennernäs; U Fagerholm; Y Raab; B Gerdin; R Hällgren
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.

Authors:  T Tenma; E Yodoya; S Tashima; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

10.  Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.

Authors:  Hideki Ichikawa; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2003-11-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.